The Switch from Reference Biologic Medicines to Biosimilars in France: The Perspective of Patients and Prescribers on Barriers and Needs.
- DOI
- 10.2147/jmdh.s528370
- Published
- 2025-10-14
- Container
- J Multidiscip Healthc
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2147/jmdh.s528370,
title = {The Switch from Reference Biologic Medicines to Biosimilars in France: The Perspective of Patients and Prescribers on Barriers and Needs.},
author = {Gaujoux-Viala C and Tropé S and Buisson A and Lacombe F and Bocquet F and Languérand E and Cordurié L and Margulies G and Le Berre C and Vittecoq O.},
year = {2025},
journal = {J Multidiscip Healthc},
doi = {10.2147/jmdh.s528370},
url = {https://doi.org/10.2147/jmdh.s528370}
}RIS
TY - JOUR TI - The Switch from Reference Biologic Medicines to Biosimilars in France: The Perspective of Patients and Prescribers on Barriers and Needs. AU - Gaujoux-Viala C AU - Tropé S AU - Buisson A AU - Lacombe F AU - Bocquet F AU - Languérand E AU - Cordurié L AU - Margulies G AU - Le Berre C AU - Vittecoq O. PY - 2025 JO - J Multidiscip Healthc DO - 10.2147/jmdh.s528370 UR - https://doi.org/10.2147/jmdh.s528370 ER -
APA
C, G., S, T., A, B., F, L., F, B., E, L., L, C., G, M., C, L. B., & O., V. (2025). The Switch from Reference Biologic Medicines to Biosimilars in France: The Perspective of Patients and Prescribers on Barriers and Needs.. J Multidiscip Healthc. https://doi.org/10.2147/jmdh.s528370
Source records
- europe-pmc · retrieved 2026-09-27T02:40:23.160Z
- hal · retrieved 2026-09-27T02:40:23.188Z